Asset
MODITHROMYCIN
Enanta Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00270517 | phase2 | unknown | 2005-12-01 | — | Enanta Pharmaceuticals, Inc | Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia |
FDA applications (0)
This company has no applications containing this asset.